ACTIONS OF 5-HYDROXYTRYPTOPHAN TO INHIBIT AND DISINHIBIT MOUSE BEHAVIOR IN THE LIGHT/DARK TEST

被引:27
作者
CHENG, CHK [1 ]
COSTALL, B [1 ]
KELLY, ME [1 ]
NAYLOR, RJ [1 ]
机构
[1] UNIV BRADFORD,SCH PHARM,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
关键词
5-HT4; RECEPTOR; LIGHT/DARK TEST; BEHAVIORAL DISINHIBITION; 5-HYDROXYTRYPTOPHAN; SDZ205-557; TROPISETRON; PUTATIVE ANXIOLYTIC;
D O I
10.1016/0014-2999(94)90080-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The involvement of 5-HT receptors in behavioural responding to an aversive situation was investigated in the mouse light/dark test. The administration of 5-hydroxytryptophan (5-HTP) (12.5-50 mg/kg i.p.) increased brain 5-HT turnover and inhibited mouse behaviour in the light/dark test box. The 5-HT2C/5-HT2A receptor antagonists methysergide (1.0 and 5.0 mg/kg i.p.) and ritanserin (0.1-1.0 mg/kg i.p.) antagonised (methysergide) or reversed (ritanserin) the effects of 5-HTP to an increased exploration of the light compartment; a low dose of the 5-HT3 receptor antagonist ondansetron (0.01 mg/kg i.p.) had a similar effect. The disinhibitory effect of the 5-HTP/ritanserin interaction was antagonised by the 5-HT3/5-HT4 receptor antagonists SDZ205-557 (0.001-0.1 mg/kg) and a high dose of tropisetron (1.0 mg/kg i.p.) but not by ondansetron (1.0 mg/kg i.p.). At these doses tropisetron and ondansetron had no effect in their own right. Thus the dominant effect of 5-HTP in the mouse is to inhibit behaviour, a response mediated via 5-HT2C/5-HT2A and 5-HT3 receptors. A 5-HT4 may effect an opposing disinhibitory potential as revealed by ritanserin.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 44 条
  • [1] ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360
  • [2] CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT
    BARNES, JM
    BARNES, NM
    CHAMPANERIA, S
    COSTALL, B
    NAYLOR, RJ
    [J]. NEUROPHARMACOLOGY, 1990, 29 (11) : 1037 - &
  • [3] Barrett J.E., 1991, 5 HT1A AGONISTS 5 HT, P59
  • [4] BOCKAERT J, 1990, MOL PHARMACOL, V37, P408
  • [5] SDZ-205-557, A SELECTIVE ANTAGONIST AT 5-HT4 RECEPTORS IN THE ISOLATED GUINEA-PIG ILEUM
    BUCHHEIT, KH
    GAMSE, R
    PFANNKUCHE, HJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (2-3) : 373 - 374
  • [6] EVIDENCE THAT CENTRAL 5-HYDROXYTRYPTAMINERGIC NEURONS ARE INVOLVED IN THE ANXIOLYTIC ACTIVITY OF BUSPIRONE
    CARLI, M
    PRONTERA, C
    SAMANIN, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) : 829 - 836
  • [7] CONN PJ, 1987, J PHARMACOL EXP THER, V242, P552
  • [8] THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS
    COSTALL, B
    NAYLOR, RJ
    TYERS, MB
    [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 181 - 202
  • [9] THE ACTIONS OF NICOTINE AND COCAINE IN A MOUSE MODEL OF ANXIETY
    COSTALL, B
    KELLY, ME
    NAYLOR, RJ
    ONAIVI, ES
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 33 (01) : 197 - 203
  • [10] COSTALL B, 1993, BRIT J PHARMACOL, V110, pP101